Pain News and Research

Latest Pain News and Research

Titan Pharmaceuticals updates on Probuphine patent application

Titan Pharmaceuticals, Inc. today announced that it has received an Office Action from the U.S. Patent and Trademark Office (PTO) rejecting the claims in the Company's method of use patent application for the use of Probuphine in the treatment of opioid addiction and chronic pain.

31 Oct 2008

Harvard study looks at quality of hospitals across the United States

The quality of hospitals across the United States is inconsistent. To address this issue, the federal government and private organizations have begun to publicly report data, such as how well hospitals treat certain conditions.

31 Oct 2008

Cimzia study shows reduction of symptoms and progression of rheumatoid arthritis

UCB has announced pivotal RAPID 1 (RA PreventIon of structural Damage) data published in Arthritis & Rheumatism shows CIMZIA (certolizumab pegol), the only PEGylated anti-TNF (Tumour Necrosis Factor alpha), together with methotrexate (MTX), rapidly reduced symptoms of disease and inhibited progression of joint damage in adult patients with active rheumatoid arthritis (RA), with sustained results for up to one year.

31 Oct 2008

GlaxoSmithKline believes there is no liver safety issue with Avandia (rosiglitazone maleate)

GlaxoSmithKline today issued the following response to a petition filed by Public Citizen to the U.S. Food and Drug Administration (FDA) on Avandia (rosiglitazone maleate), a highly effective therapy for treating type 2 diabetes when used in the appropriate patient population.

31 Oct 2008

Pulsed ultrasound used to remote control brain circuits

In a twist on nontraditional uses of ultrasound, a group of neuroscientists at Arizona State University has developed pulsed ultrasound techniques that can remotely stimulate brain circuit activity.

29 Oct 2008

As many as 4,600 Australian children affected by juvenile arthritis

Experts say as many as 4,600 Australian children under the age of 16 suffer from juvenile arthritis.

29 Oct 2008

FDA warns Bayer HealthCare on over-the-counter aspirin product

The U.S. Food and Drug Administration today sent Warning Letters to Bayer HealthCare concerning two unlawful, over-the-counter (OTC) aspirin products - Bayer Women's Low Dose Aspirin + Calcium (Bayer Women's) and Bayer Aspirin with Heart Advantage (Bayer Heart Advantage).

28 Oct 2008

New drug combo stops rheumatoid arthritis in its tracks

The trial of a new drug for rheumatoid arthritis (RA) has revealed that an injection once a month could stop the disease progressing.

28 Oct 2008

Colonoscopy prep harder on women than men

Colonoscopy is especially important for women, because they're more likely to have polyps or lesions deeper in the colon. Only colonoscopy examines the entire length of the colon. Emptying the contents of the colon - a step called bowel prep - is essential to a successful colonoscopy. But there's some reason to believe that bowel prep for a colonoscopy is harder for women than for men, reports the November 2008 issue of Harvard Women's Health Watch.

27 Oct 2008

Study reveals factors of exceptional health in old age

Elderly people who have a positive outlook, lower stress levels, moderate alcohol consumption, abstention from tobacco, moderate to higher income and no chronic health conditions are more likely to thrive in their old age, according to a study in the October issue of the Journals of Gerontology, Medical Sciences.

27 Oct 2008

Bisphosphonates for osteoporosis increase risk for heart problems

People who take bisphosphonates for osteoporosis may be at risk for serious atrial fibrillation (AF), or irregular heartbeats, according to a new study.

27 Oct 2008

New gout drug offers hope for those who have exhausted treatment options

Researchers in the U.S. say a new drug effectively treats serious cases of gout - the drug called pegloticase mimics a blood-clearing enzyme missing in humans and helps remove the build up in uric acid, which causes the painful, needle-like crystals to collect around fingers, toes and other joints.

27 Oct 2008

First-ever international guidelines for the treatment of psoriatic arthritis

Rheumatologists, dermatologists, and patient advocates have come together to publish the first-ever international guidelines for the treatment of psoriatic arthritis, a disease that mainly affects people who have psoriasis but also some people without it.

26 Oct 2008

High dose flu vaccine boosts immune response in elderly

Giving people age 65 and older a dose four times larger than the standard flu vaccine boosts the amount of antibodies in their blood to levels considered protective against the flu, more so than the standard flu vaccine does. The findings from a study of nearly 4,000 people were presented Oct. 26 at a national meeting on infectious diseases.

26 Oct 2008

NanoVibronix receives FDA clearance for PainShield diathermy device

NanoVibronix, a medical device company, announced that the US Food and Drug Administration (FDA) has granted 510K clearance to market PainShield MD, a diathermy device used to treat pain. PainShield is the first hands-free, patch-based diathermy device, thus allowing for an entirely new dimension in ultrasound treatment of pain and soft tissue healing. The PainShield consists of a disposable patch connected to a portable reusable driver and generates ultrasound waves to the desired area of the body.

23 Oct 2008

Providing pain relief with computers

Pain relief is big business - very big business - which is why Dr Adrian Mulholland in the School of Chemistry has just won an EPSRC Leadership Fellowship grant of nearly £1million, part of which will be used to further his research into designing drugs for pain relief. However, he never goes near a lab, doing it all from his computer.

23 Oct 2008

Nymox nears completion of benign prostatic hyperplasia drug trial

Nymox Pharmaceutical Corporation has announced that the Company's latest multi-center U.S. study of NX-1207, its investigational drug for the treatment of benign prostatic hyperplasia (BPH), is nearing completion.

23 Oct 2008

Could brain abnormality predict drug addiction?

Scientists at The University of Nottingham are to use MRI technology to discover whether abnormalities in the decision-making part of the brain could make some people more likely to become addicted to drugs.

22 Oct 2008

Developing depression after a heart attack increases one’s risk of death or readmission

Science has found many links between depression and other serious medical illnesses, such as cancer, stroke, diabetes, and heart disease. For example, people who develop depression following a heart attack (myocardial infarction) or chest pain (angina) have an elevated risk of cardiac death or hospital readmission over the following year.

22 Oct 2008

Teva granted FDA approval for Fentanyl transdermal system

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) for Fentanyl Transdermal System, 25 mcg/hour, 50 mcg/hour, 75 mcg/hour and 100 mcg/hour, the AB-rated generic equivalent of Ortho McNeil's chronic pain treatment Duragesic. Shipment of this product has commenced.

20 Oct 2008

Pain News and Research

Latest Pain News and Research

Titan Pharmaceuticals updates on Probuphine patent application

Harvard study looks at quality of hospitals across the United States

Cimzia study shows reduction of symptoms and progression of rheumatoid arthritis

GlaxoSmithKline believes there is no liver safety issue with Avandia (rosiglitazone maleate)

Pulsed ultrasound used to remote control brain circuits

As many as 4,600 Australian children affected by juvenile arthritis

FDA warns Bayer HealthCare on over-the-counter aspirin product

New drug combo stops rheumatoid arthritis in its tracks

Colonoscopy prep harder on women than men

Study reveals factors of exceptional health in old age

Bisphosphonates for osteoporosis increase risk for heart problems

New gout drug offers hope for those who have exhausted treatment options

First-ever international guidelines for the treatment of psoriatic arthritis

High dose flu vaccine boosts immune response in elderly

NanoVibronix receives FDA clearance for PainShield diathermy device

Providing pain relief with computers

Nymox nears completion of benign prostatic hyperplasia drug trial

Could brain abnormality predict drug addiction?

Developing depression after a heart attack increases one’s risk of death or readmission

Teva granted FDA approval for Fentanyl transdermal system

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Pain News and Research

Latest Pain News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in